Long-Term Remissions in Metastatic Malignant Melanoma Following Chemotherapy and Tamoxifen Maintenance

Publisher： Karger

E-ISSN： 2296-5262|34|4|208-209

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.34, Iss.4, 2011-03, pp. : 208-209

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Treatment Effect or Secret Nature: Long-Term Remissions in Metastatic Pancreatic Cancer

By  

Oncology Research and Treatment, Vol. 33, Iss. 11, 2010-10 ,pp. : 581-582

Karger

Access to resources Recommend Favorite

Dacarbazine, Nimustine Hydrochloride, Cisplatin and Tamoxifen Combination Chemotherapy for Advanced Malignant Melanoma

By  

THE JOURNAL OF DERMATOLOGY, Vol. 26, Iss. 8, 1999-08 ,pp. : 489-493

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Survival Analysis in Metastatic Melanoma: Serum S100B Is an Independent Prognostic Marker and Superior to LDH

By  

Oncology Research and Treatment, Vol. 31, Iss. 7, 2008-06 ,pp. : 380-384

Karger

Access to resources Recommend Favorite

Clinicopathologic features associated with efficacy and long‐term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitors

By  

CANCER, Vol. 121, Iss. 21, 2015-11 ,pp. : 3826-3835

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic Factors in Metastatic Malignant Melanoma

By  

Oncology, Vol. 55, Iss. 1, 1997-12 ,pp. : 59-64

Karger

Access to resources Recommend Favorite